We are live on ! Find out more
UTHR icon

United Therapeutics

383 hedge funds and large institutions have $8.87B invested in United Therapeutics in 2015 Q2 according to their latest regulatory filings, with 70 funds opening new positions, 132 increasing their positions, 138 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more call options, than puts

Call options by funds: $64.9M | Put options by funds: $40M

43% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 49

5% more funds holding

Funds holding: 366383 (+17)

2% less capital invested

Capital invested by funds: $9.02B → $8.87B (-$146M)

4% less repeat investments, than reductions

Existing positions increased: 132 | Existing positions reduced: 138

33% less funds holding in top 10

Funds holding in top 10: 1510 (-5)

Holders
383
Holders Change
+17
Holders Change %
+4.64%
% of All Funds
10.32%
Holding in Top 10
10
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-33.33%
% of All Funds
0.27%
New
70
Increased
132
Reduced
138
Closed
49
Calls
$64.9M
Puts
$40M
Net Calls
+$24.9M
Net Calls Change
-$9.86M
Name Holding Trade Value Shares
Change
Change in
Stake
SFP
201
Santa Fe Partners
New Mexico
$1.95M +$2.02M +11,211 New
Baird Financial Group
202
Baird Financial Group
Wisconsin
$1.95M +$2.02M +11,202 New
TRSOTSOK
203
Teachers Retirement System of the State of Kentucky
Kentucky
$1.95M
HHC
204
Hutchin Hill Capital
New York
$1.93M +$2M +11,100 New
AI
205
Analytic Investors
California
$1.92M -$39.2K -218 -2%
VRS
206
Virginia Retirement Systems
Virginia
$1.84M -$473K -2,627 -20%
MAM
207
Meeder Asset Management
Ohio
$1.84M -$149K -830 -7%
Janney Montgomery Scott
208
Janney Montgomery Scott
Pennsylvania
$1.8M +$2.52K +14 +0.1%
VIA
209
Vident Investment Advisory
Georgia
$1.8M +$254K +1,410 +16%
TSW
210
Thompson Siegel & Walmsley
Virginia
$1.76M -$3.6K -20 -0.2%
M&T Bank
211
M&T Bank
New York
$1.75M -$859K -4,776 -32%
MACM
212
March Altus Capital Management
Connecticut
$1.74M -$144K -799 -7%
BAMS
213
Bellevue Asset Management (Switzerland)
Switzerland
$1.62M
CFA
214
CT Financial Advisors
Pennsylvania
$1.59M -$94.4K -525 -5%
BCIM
215
British Columbia Investment Management
British Columbia, Canada
$1.52M +$1.57M +8,752 New
CCG
216
Chatham Capital Group
Georgia
$1.51M
CIP
217
Convergence Investment Partners
Florida
$1.5M +$1.56M +8,650 New
URS
218
Utah Retirement Systems
Utah
$1.46M -$54K -300 -3%
B
219
Barings
North Carolina
$1.44M +$425K +2,360 +40%
PP
220
Paloma Partners
Connecticut
$1.41M -$1.92M -10,658 -57%
JIC
221
Johnson Investment Counsel
Ohio
$1.32M
EVM
222
Eaton Vance Management
Massachusetts
$1.3M
LPL Financial
223
LPL Financial
California
$1.3M -$218K -1,213 -14%
Tudor Investment Corp
224
Tudor Investment Corp
Connecticut
$1.28M +$1M +5,575 +310%
CWM
225
Concert Wealth Management
California
$1.28M +$1.32M +7,350 New

UTHR Hedge Fund Activity: Q2 2015 in Review

383 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2015, worth a combined $8.87B — down 1.6% from $9.02B a quarter earlier.

Buyers outnumbered sellers: 70 funds opened new UTHR positions and 49 closed out — a net gain of 21 holders — while 132 added to existing stakes and 138 trimmed.

The largest buyer was Putnam Investments, adding an estimated $92.2M. The largest seller was TimesSquare Capital Management, cutting an estimated $140M.

  • 383 institutional investors held United Therapeutics (UTHR) as of Q2 2015, up from 366 in Q1 2015.
  • Funds reported $8.87B of United Therapeutics stock for Q2 2015, down 1.6% quarter-over-quarter.
  • 70 funds opened new United Therapeutics positions in Q2 2015 and 49 closed out, a net change of +21 holders.
  • The largest United Therapeutics buyer in Q2 2015 was Putnam Investments, an estimated $92.2M added.
  • The largest United Therapeutics seller in Q2 2015 was TimesSquare Capital Management, an estimated $140M sold.

Based on aggregated 13F filings for Q2 2015.